23 Diagnostic study Analysis of germline and somatic January 2014 genetic alterations in 429 ovarian Kanchi KL, Johnson KJ, Lu C, McLennan MD, et.al. cancer and 557 controls. Germline and tumour DNA were Nature Communications, 2014, 5:3156 sequenced by exome capture followed by next generation sequencing on Illumina or SOLiD platforms. 24 Diagnostic A study investigating temporal October 2013 heterogeneity, in particular the Pennington K, Walsh T, Harrell M, Lee M stability of somatic mutations over time, in paired primary and Gynecologic Oncology, 2013, 131(1):258. recurrent ovarian carcinomas. Neoplastic and germline DNA was extracted by targeted capture (BROCA panel) from 23 paired samples primary and recurrent ovarian, fallopian tube and peritoneal carcinomas and mutations were detected using massively parallel genomic sequencing (next generation sequencing).
23 Diagnostic study Analysis of germline and somatic genetic alterations in 429 ovarian cancer and 557 controls. Germline and tumour DNA were sequenced by exome capture followed by next generation sequencing on Illumina or SOLiD platforms. Kanchi KL, Johnson KJ, Lu C, McLennan MD, et.al. Nature Communications, 2014, 5:3156 January 2014 24 Diagnostic A study investigating temporal heterogeneity, in particular the stability of somatic mutations over time, in paired primary and recurrent ovarian carcinomas. Neoplastic and germline DNA was extracted by targeted capture (BROCA panel) from 23 paired samples primary and recurrent ovarian, fallopian tube and peritoneal carcinomas and mutations were detected using massively parallel genomic sequencing (next generation sequencing). Pennington K, Walsh T, Harrell M, Lee M Gynecologic Oncology, 2013, 131(1):258. October 2013